Drug Eluting Stents
10 Years of Clinical Safety and Efficacy Data: German Excellence in Drug-Eluting Stent Technology
As a leading innovator in cardiovascular solutions, we offer a range of advanced drug-eluting stents, including our polymer-free stents, all CE-approved and backed by 10 years of clinical data. With a foundation in the science of the German Heart Center, our stents deliver superior safety, precision, and long-term efficacy. From pioneering R&D and expert manufacturing to rigorous quality control and clinical research, we are committed to providing superior heart health solutions. Our comprehensive approach ensures excellence across all stages of development and patient care.
Future Beyond Polymers with 10 Years of Safety and Efficacy Data (ISAR TEST-5)
Longest-studied Polymer-Free Sirolimus-Eluting Stent, with 10 years of proven safety and efficacy data from the ISAR TEST-5 trial. Built on a Cobalt Chromium platform, features a proprietary formulation of Sirolimus with drug delivery matrix of Probucol and Shellac Resin. Probucol replaces traditional polymers, ensuring controlled drug release, enhanced vascular healing, and unmatched safety. The unique micro-porous surface and abluminal coating further optimize drug delivery and healing.
Next Generation Biodegradable Polymer Technology
Sirolimus-eluting stent featuring a biodegradable polymer and a unique micro-porous PEARL surface, favours better endothelialisation and optimal drug delivery. With 10 years of clinical data, it demonstrates improved long-term performance compared to first-generation DES. The stent’s innovative 2-strut connector design ensures maximum flexibility and optimal side branch access, making it ideal for bifurcation stenting.
Redefining Flexibility in Coronary Stents
Sirolimus-eluting biodegradable polymer stent on a Cobalt Chromium platform, designed for enhanced flexibility and navigation through tortuous anatomy. The unique micro-porous surface and abluminal drug coating optimize drug delivery for longer duration. Backed by 10 years of RCT data, it demonstrates proven safety and efficacy compared to Xience.
New generation DES providing synergy
CE-approved Sirolimus-eluting coronary stent built on a microporous PERAL surface stainless-steel platform with a biodegradable polymer. It boasts 10 years of RCT data from the ISAR TEST-4, demonstrating its safety and efficacy compared to the Xience stent. Additionally, it is recommended by the ESC 2018 guidelines.
Ultimate Trackability for Treating Complexity
CE-approved Sirolimus-Eluting Biodegradable Polymer Coronary Stent features a Cobalt Chromium platform, and a Stent Delivery System designed for balanced performance, making it suitable for use across all types of vessel anatomies. Backed by 10 years of clinical data, it demonstrates proven safety and efficacy.
